
Sherene Loi/LinkedIn
Jun 9, 2025, 09:26
Sherene Loi Shares Final Results of IMpassion031 in Early Triple-Negative Breast Cancer
Sherene Loi, Medical Oncologist, Lab Head of Breast Oncology Clinical Trials at Peter MacCallum Cancer Centre, posted on X:
“Final results of IMpassion031.
Neoadj Atezo in early TNBC Final EFS HR~ Gepardouze. ctDNA neg by Signatera not sensitive enough to say patients are cured but small % who were pos did poorly. Hopefully next gen ctDNA assays will be better.”
More posts featuring Breast Cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 9, 2025, 09:25
Jun 9, 2025, 09:19
Jun 9, 2025, 09:13